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Abstract T-cadherin (T-cad) is an unusual glycosylphosphatid-
ylinositol-anchored member of the cadherin family of cell
adhesion molecules. Binding of low density lipoproteins (LDLs)
to T-cad can be demonstrated on Western blots of smooth muscle
cell lysates, membranes and purified proteins. Using HEK293
cells transfected with human T-cad cDNA (T-cad+), we have
investigated the adhesion properties of expressed mature and
precursor proteins and examined the postulate that LDL
represents a physiologically relevant ligand for T-cad. T-cad+
exhibits an increased Ca2+-dependent aggregation (vs. control)
that was reduced by selective proteolytic cleavage of precursor
T-cad and abolished after either proteolytic or phosphatidylino-
sitol-specific phospholipase C (PI-PLC) cleavage of both mature
and precursor proteins, indicating that both proteins function in
intercellular adhesion. T-cad+ exhibited a significantly increased
specific cell surface-binding of [125I]-LDL that was sensitive to
PI-PLC pre-treatment of cells. Ca2+-dependent intercellular
adhesion of T-cad+ was significantly inhibited by LDL. Our
results support the suggestion that LDL is a physiologically
relevant ligand for T-cad.
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1. Introduction
Cadherins comprise a family of Ca2-dependent adhesion
receptors that usually engage in homotypic cell-cell adhesion
and play a critical role in establishment of cell polarity and
tissue morphogenesis [1^5]. T-cadherin (T-cad) is principally
distinct from other cadherins in that although its extracellular
domain contains mostly the features of classical type I cad-
herin extracellular domains, it lacks transmembrane and cy-
tosolic domains and is instead attached to the plasma mem-
brane through a glycosylphosphatidylinositol (GPI) moiety
[6,7]. T-cad was originally identi¢ed in chicken neuronal plas-
ma membrane [6], but has since been found to be expressed in
diverse tissues (e.g. brain, aorta, skeletal muscle, heart, kid-
ney) [6,8^11] as well as in diverse cultured cells (cardiomyo-
cytes, ¢broblasts, epithelial cells, neuronal cells, smooth
muscle cells (SMCs)) [9,12^14]. The biological functions of
T-cad are not well understood. CHO cells transfected with
chicken T-cad form aggregates in the presence of Ca2, but
T-cad seems to confer a weaker adhesive function than other
cadherins [7]. Studies on the developing chick neuron [15,16]
and human mammary carcinomas [9] have indicated that T-
cad might serve a homotypic avoidance mechanism and there-
by a negative function in growth control. A cell density and
proliferation status-dependence of T-cad protein levels in
SMCs also supports some function relevant to negative con-
trol of cell-cell contact and proliferation in the vasculature
[17].
In addition to mediation of cell-cell adhesion through ho-
mophilic extracellular domain interactions [5,18^21], some
members of the cadherin superfamily can participate in signal
transduction pathways through interactions between the cad-
herin cytoplasmic domain, the catenin group of submembra-
neous proteins [3,22^26] and other cytoplasmic signalling mol-
ecules such as a SHC adapter protein [27], tyrosine kinases
and protein tyrosine phosphatases [28]. On the basis of its
expression at the apical surface of epithelial cells, a potential
role for T-cad in receiving and transducing signals has also
been proposed [12]. T-cad does not possess a cytoplasmic
domain but has been shown to co-localize with key signal
transducing molecules such as GK and kinases of the src fam-
ily within caveolin-enriched detergent-insoluble low density
membrane domains of SMCs [8,14]. As is the case for several
other GPI-anchored proteins [25,29], such a ‘caveolar’ loca-
tion could conceivably endow T-cad with an ability to func-
tion as a signal transducing molecule.
In terms of signal transduction, it is relevant to question
whether any members of the cadherin superfamily, including
T-cad, can interact with extracellular non-cadherin (hetero-
philic) molecules. Blotting analysis of either whole cell lysates,
plasma membranes, caveolar fractions or puri¢ed protein
preparations has revealed consistent co-localization of anti-
T-cad immunoreactivity and low density lipoprotein (LDL)-
binding [10,11,13,14,17], suggesting that LDL may represent a
speci¢c heterophilic ligand for T-cad. This postulate is based
exclusively on data obtained by ligand- and immunoblotting
analyses of whole cell lysates or membrane preparations after
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and electrotransfer to nitrocellulose membranes.
It has not been demonstrated yet that LDL is capable of
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binding to cell surface-expressed T-cad. Using HEK293 cells
stably transfected with human T-cad, we report on the prop-
erties of this glycoprotein with respect to cell-cell adhesion
and LDL-binding, as well as the in£uence of LDL on cell-
cell adhesion.
2. Materials and methods
2.1. Cell culture and transfection
Human embryonic kidney cells (HEK293) that permanently ex-
pressed GPI-anchored human pre-pro T-cad were obtained by clonal
selection (on 800 Wg/ml geneticin) after stable transfection with the
expression vector pCINeo (Promega, Zurich, Switzerland) harboring
T-cad cDNA corresponding to nucleotides 445^2586 (EMBL database
accession code L34058). Experiments described herein used clone N8
(HEK293 cells stably transfected with human pre-pro T-cad (T-
cad+)). One geneticin-resistant clone after transfection of parental
HEK293 cells (wt) with pCINeo was used as the vector control
(mock-transfected HEK293 cells (mock)). Neither wt nor mock cells
express T-cad as determined by Northern, Western and FACScan
analyses. For the experiments described herein, cultures were main-
tained (unless otherwise speci¢ed) in DMEM containing 5 mM glu-
tamine, 100 U/ml, penicillin, 100 U/ml streptomycin, 10 mM TES-
NaOH, 10 mM HEPES-NaOH (each at pH 7.3) and 5% fetal calf
serum (DMEM/FCS).
2.2. Antisera
Generation of polyclonal rabbit antiserum to synthetic peptides
corresponding to human T-cad precursor amino acid positions [140^
161], [161^179] and [260^271] [10,30]. Anti-[161^179] peptide antisera
(AS161ÿ179) were used for immunoblot analysis and a mixture of the
three di¡erent antisera ([140^161]:[161^179]:[260^271] at 1:1:2) was
used in the FACS and FACScan applied for selection of stable T-cad
transfectants.
2.3. Lipoproteins
LDL (b 1.019^1.063 g/ml) and high density lipoprotein (HDL3 ;
b 1.125^1.215 g/ml) were isolated from the plasma of healthy male
humans using the sequential buoyant density centrifugation technique
[31,32]. LDL was biotinylated using D-biotin-N-hydroxysuccinimide
[13,33] and iodinated (speci¢c activity 200^400 cpm/ng) using the io-
dine monochloride method [32,34].
2.4. Immuno- and ligand-blot analyses
The methods of immunoblotting (using AS161ÿ179) and ligand-blot-
ting (using biotinylated LDL) have been detailed previously [13,35,36].
A partially puri¢ed preparation of 105 kDa T-cad protein from
human aortic media [10] or lysates of human aortic SMCs [13,14]
served as positive controls for LDL-binding and T-cad immunoreac-
tivity.
2.5. [125I]-Lipoprotein-binding
Cells (at 70% con£uency) were transferred to serum-free minimal
essential medium (MEM/bovine serum albumin (BSA)) containing
Earle’s salts, 100 U/ml, penicillin, 100 U/ml streptomycin, 10 mM
TES-NaOH, 10 mM HEPES-NaOH (each at pH 7.3), 5 mM gluta-
mine, 1 mg/ml BSA and cultured for a further 36 h in the presence of
5 Wg/ml 25P- hydroxycholesterol. All subsequent washing and incuba-
tion procedures were conducted at 4‡C. Cells were collected, washed
twice with and suspended (5U106/ml) in binding bu¡er (MEM/BSA).
Aliquots of cell suspensions were taken for Lowry protein determina-
tion after removal of BSA by repeated washes with phosphate-bu¡-
ered saline (PBS). Saturation binding of [125I]-LDL (5^100 Wg/ml) to
50 Wl aliquots of cell suspension (quadruplicate wells for each point)
was conducted for 4 h in a ¢nal volume of 100 Wl/well in 96 well dishes
(Packard ViewPlate-96). Parallel dishes contained excess (1 mg/ml)
unlabelled LDL for determination of non-speci¢c binding. Binding
incubations were terminated by centrifugation and washing (three
times) with PBS containing 1 mM CaCl2, 1 mM MgCl2, 2 mg/ml
BSA). Cell bound [125I]-LDL was quantitated by addition of 50 Wl
Packard MicroScint-20 and counting in a microplate scintillation
counter. Data for speci¢c binding were analyzed by non-linear regres-
sion to determine the maximal binding capacity (Bmax) and the dis-
sociation constant (Kd).
2.6. Aggregation
Subcon£uent cultures were collected by suspension and washed
twice in PBS containing 10 mM HEPES-NaOH (pH 7.3). Cells were
resuspended in this bu¡er and divided into three aliquots to which
either EGTA (2 mM ¢nal), trypsin/EGTA (0.025%, 2 mM ¢nal) or
trypsin/CaCl2 (0.025%, 1 mM ¢nal) was added. After incubation for
20 min at 37‡C, cells were pelleted by centrifugation, resuspended in
PBS containing 1 mM MgCl2, soybean trypsin inhibitor (0.1% v/v)
and DNase I (60 Wg/ml) and incubated for a further 30 min at 37‡C.
Cells were then washed and ¢nally resuspended in PBS containing
10 mM HEPES-NaOH (pH 7.3), 1 mg/ml BSA, 1 mM EGTA and
maintained at 4‡C. Aliquots of cell suspensions were withdrawn and
processed for immunoblot analysis. For determination of the in£uence
of LDL on intercellular adhesion, subcon£uent cultures were collected
by suspension, washed twice with PBS containing 10 mM HEPES-
NaOH (pH 7.3), 1 mg/ml BSA and 1 mM EGTA and cells resus-
pended (5U106 cells/ml) in the same and maintained at 4‡C. Before
the start of aggregation assays, cells were carefully resuspended to
ensure single cell suspensions and viability of cells (s 90%) was con-
trolled by trypan blue exclusion. Aggregation assays (conducted at
37‡C with gyration at 70 rpm in Non-Tissue Culture Treated 24
well Falcon dishes) were started by addition of 50 Wl cell suspension
to 500 Wl pre-warmed (37‡C) PBS containing 1 mg/ml BSA, 10 mM
HEPES-NaOH (pH 7.3) and either 2 mM CaCl2 or 2 mM EGTA.
Incubations were terminated by addition of 500 Wl 5% glutaraldehyde
in PBS and particle numbers were determined on a Coulter Counter
Model T4 (100 W aperture). Unless otherwise stated, aggregation is
expressed as the fractional loss of particle number, Nt/N0, where N0 is
the particle number at time 0 and Nt the particle number after any
given time point.
2.7. Statistics
Statistical evaluation of di¡erences was performed using Student’s
t-test for paired observations. Di¡erences were considered to be sig-
ni¢cant at P6 0.05.
3. Results
3.1. Speci¢c binding of LDL to cell surface-expressed human
T-cad
Immunoblot and ligand-blot analyses were applied to iden-
tify anti-T-cad immunoreactive proteins (Fig. 1A) and LDL-
binding proteins (Fig. 1B) in whole cell lysates from wt, T-
cad+ and mock cells. Only T-cad+ cells expressed anti-T-cad
immunoreactive proteins (Fig. 1A, lane 3) and both the ex-
pected mature (105 kDa) and precursor (130 kDa) forms of T-
cad [7,10,11] were present. Ligand-blot analysis revealed bind-
ing of LDL to both 105 and 130 kDa proteins in T-cad+ cells
only, which co-localized with T-cad immunoreactive proteins
(cf. lanes 3 in Fig. 1A,B). Minor binding of LDL to a 105
kDa protein (but not immunoreactive) could also be detected
in wt (Fig. 1B, lane 4) and mock (Fig. 1B, lane 5) cells.
Saturation binding studies (using [125I]-LDL) were per-
formed on intact cell cultures to determine whether cell sur-
face-expressed T-cad is capable of binding LDL. Speci¢c and
saturable binding of [125I]-LDL at 4‡C was observed for all
cell types (Fig. 2A). Scatchard plots of binding parameters
(inset to Fig. 2A) tended to be non-linear in T-cad+, wt and
mock cells, but non-linear regression assessment of the bind-
ing parameters did not indicate a statistically signi¢cant im-
provement of ¢t of the data to a two-site model, compared
with a one-site model (data not shown). Non-linear regression
analysis of saturation pro¢les for a one-site model revealed a
signi¢cantly increased Bmax for T-cad+ cells as compared with
wt and mock cells (Fig. 2B). There were no signi¢cant di¡er-
ences with respect to Kd values (Fig. 2B). To substantiate
recognition of LDL by T-cad, speci¢c binding at a single,
saturating concentration of [125I]-LDL (75 Wg/ml) was deter-
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mined in cells which were pre-treated with phosphatidylinosi-
tol-speci¢c phospholipase C (PI-PLC) (5 U/ml, 2 h at 37‡C in
DMEM) to remove cell surface T-cad [7,11,13]. Loss of T-cad
proteins was veri¢ed after immunoblot analysis of whole cell
lysates (data not shown). PI-PLC treatment did not a¡ect
speci¢c binding of [125I]-LDL (cpm/105 cells, mean þ S.D.,
n = 3) in mock cells (1140 þ 270 in untreated cells vs.
968 þ 106 in treated cells). In contrast, speci¢c [125I]-LDL-
binding in PI-PLC-treated T-cad+ cells was signi¢cantly less
than that in untreated T-cad+ (1570 þ 312 vs. 2849 þ 404,
P6 0.01). These experiments demonstrate that cell surface-ex-
pressed T-cad recognizes LDL as a speci¢c ligand.
3.2. Ca2+-dependent aggregation
In order to establish that recombinantly expressed human
T-cad mediates the expected function of Ca2-dependent ad-
hesion, we compared the aggregative properties of suspensions
of T-cad+ and mock cells under Ca2-free (presence of 2 mM
EGTA) and Ca2-containing (2 mM CaCl2) incubation con-
ditions (Fig. 3). Both cell types exhibited Ca2-independent
aggregation, this being slightly more pronounced in T-cad+
cells. Ca2-dependent aggregation was signi¢cantly greater in
T-cad+ cells compared with mocks (W65% vs. 30% after
90 min, P6 0.005 at 30, 60 and 90 min) (Fig. 3).
To ensure that the exaggerated Ca2-dependent aggregation
of T-cad+ cells is indeed due to T-cad, we exploited the char-
acteristic resistance of cadherins to proteolytic degradation in
the presence of Ca2 [7,37,38]. Aggregation assays were con-
ducted using control cells (E) and cells pre-treated with tryp-
sin either in the absence (T/E) or presence (T/C) of Ca2. In
accordance with previous ¢ndings in chicken T-cad-trans-
fected CHO cells [7] and SMCs [13], immunoblot analysis
(data not shown) revealed almost complete loss of both 105
and 130 kDa proteins in T/E-treated T-cad+ cells, whereas in
T/C-treated cells, there was a loss of 130 kDa protein and
concomitant increase in 105 kDa protein. Compared with
control untreated cell suspensions (Fig. 4A), T/E-pre-treated
T-cad+ and mock cells exhibited reduced aggregatability (Fig.
4B). Loss of aggregatability was particularly prominent in T-
cad+ cells (extent of aggregation reduced from W60% to 20%
after 90 min) and residual aggregatability after T/E pre-treat-
ment was comparable between T-cad+ and mock cells (Fig.
4B). Although T/C-pre-treatment resulted in some loss of ag-
gregatability in T-cad+ cells, their extent of aggregation re-
mained signi¢cantly greater than T/C-pre-treated mock cells
(W40% vs. 25% after 90 min, P6 0.005) (Fig. 4C). This di¡er-
ence between T/C-pre-treated T-cad+ and mock cells was not
evident when the aggregation assay was conducted under
Fig. 1. Co-localization of LDL-binding and T-cad immunoreactivity
in HEK293 cells expressing human T-cad. Whole cell lysates (20 Wg/
lane) from T-cad+ (lane 3), wt (lane 4) and mock (lane 5) cells were
electrophoresed, transferred to nitrocellulose and examined for im-
munoreactivity to anti-T-cad antiserum (A) and binding of biotin-
ylated LDL (B). Lysates of human aortic SMCs which contain
both 105 and 130 kDa forms of T-cad (lane 1) and a partially puri-
¢ed preparation of 105 kDa T-cad from human aortic medial tissue
(lane 2) served as positive controls. The barely discernible protein at
130 kDa in lysates from wt and mock cells (lanes 4 and 5) repre-
sents non-speci¢c immunoreactivity (non-immune control blot not
shown).
Fig. 2. Expression of human T-cad in HEK293 cells leads to an in-
creased capacity for surface LDL-binding. Surface-binding of [125I]-
LDL to T-cad+ (closed circles), mocks (closed triangles) and wt
(open circles) was determined as described under Section 2. Satura-
tion pro¢les for speci¢c surface-binding and Scatchard transforma-
tion of the data (inset) are shown in A. Lines within the Scatchard
plots were derived by linear regression analysis of the transformed
data. Non-linear regression analysis was applied to determine the
binding parameters Bmax (B) and Kd (C). Data (means þ S.E.M.)
were obtained from eight, six and six independent experiments for
T-cad+, mock and wt cells, respectively. Asterisks indicate signi¢-
cant di¡erences between T-cad+ and mock cells (P6 0.01) and be-
tween T-cad+ and wt cells (P6 0.01).
Fig. 3. Human T-cad expressing HEK293 cells exhibit increased
Ca2-dependent aggregation. Aggregation of T-cad+ (circles) and
mock (triangles) cells in the absence (open symbols, dashed lines)
and presence (closed symbols) of Ca2 was assayed as described
under Section 2. Aggregation is expressed as a reduction in particle
number relative to that number at time zero and data represent
means þ S.E.M. from ¢ve independent experiments. Mock and wt
cells (data not shown) did not di¡er with respect to either Ca2-in-
dependent or Ca2-dependent aggregation.
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Ca2-free conditions (Fig. 4D). Data obtained for wt cells
were qualitatively and quantitatively comparable to those pre-
sented for mock cells (data not shown). The increased aggre-
gatability of T-cad+ cells could also be normalized after re-
moval of surface T-cad by treatment of cells with PI-PLC
(data not shown) as shown previously in CHO cells trans-
fected with chick T-cad [7]. When the aggregation assay was
conducted on a 1:1 mixture of T-cad+ and mock (or wt) cells
(total cell density of 5U105 cells/ml in the assay), the extent of
aggregation in the presence of Ca2 after 90 min was found to
be signi¢cantly less in comparison to that determined in
T-cad+ cells alone (N90/N0 values of 0.64 þ 0.08 vs.
0.38 þ 0.05, respectively, P6 0.001; mean þ S.D., n = 4). Taken
together, these data con¢rm that the enhanced Ca2-depend-
ent adhesion in T-cad+ cells is mediated by cell surface-ex-
pressed T-cad.
3.3. LDL interferes with T-cad-mediated cell-cell adhesion
To determine whether LDL was able to in£uence T-cad-
mediated aggregation, assays were conducted on EGTA-dis-
sociated cultures under Ca2-containing conditions without or
with inclusion of lipoproteins. LDL exerted a dose-dependent
inhibitory e¡ect on aggregation of T-cad+ cells, this e¡ect
achieving signi¢cance at v50 Wg/ml (Fig. 5A). In mock cells,
there was a tendency towards reduced aggregation at LDL
concentrations of v100 Wg/ml, but this was not signi¢cant,
and at the higher concentrations of LDL (i.e. 100^200 Wg/
ml), the extent of aggregation in mock and T-cad+ cells was
comparable (Fig. 5A). We could not detect a signi¢cant in-
hibitory e¡ect of HDL3 (25^200 Wg/ml) on aggregation (Fig.
5B, data for 100 Wg/ml shown only).
4. Discussion
Human T-cad expressed in HEK293 cells is functional in
mediating Ca2-dependent intercellular adhesion, as evi-
denced by the increased aggregation of T-cad+ cells and nor-
malization thereof after cleavage of cell surface T-cad either
by trypsinolysis of cells in the absence of Ca2 (T/E) or treat-
ment of cells with PI-PLC. Of interest is whether precursor
T-cad is functional in mediating adhesion. Aggregatability of
T-cad+ cells following selective removal of precursor T-cad
protein by proteolysis in the presence of Ca2 was less than
that of cells containing both precursor and mature proteins,
suggesting that both mature and precursor T-cad proteins
possess adhesive properties. This might seem surprising since
surface expression of a mutant E-cadherin containing the pre-
peptide has been shown to be non-functional in mediating
cell-cell adhesion [39]. However, in contrast to the classical
cadherins (e.g. E-cadherin) which are transported to the cell
surface as mature protein only subsequent to intracellular
Fig. 4. E¡ect of proteolysis under Ca2-free and Ca2-containing conditions on aggregation potential. Intact T-cad+ (closed symbols) and
mock cells (open symbols) were treated with either EGTA (A), trypsin/EGTA (B) or trypsin/Ca2 (C and D) as described in Section 2 and
then assayed for their ability to aggregate in the presence of Ca2 (A^C) or EGTA (D). Aggregation is expressed as a reduction in particle
number relative to that number at time zero and data represent means þ S.E.M. The numbers of independent experiments performed were 12,
nine, 10 and four for A, B, C and D, respectively.
Fig. 5. LDL dose-dependently inhibits aggregation in HEK293 cells
expressing human T-cad. Aggregation of T-cad+ (closed symbols,
hatched bars) and mock (open symbols, open bars) cells was deter-
mined after 60 min incubation in the presence of Ca2 without or
with inclusion of the indicated concentrations of LDL (A and B) or
HDL3. Data are expressed as % of cells in aggregates (i.e. [N03N60/
N0]U100) and represent the means þ S.E.M. of ¢ve (A) and four
(B) independent experiments. Asterisks in A indicate where aggrega-
tion of T-cad+ cells incubated in the presence of LDL di¡ered sig-
ni¢cantly from those incubated under control conditions. Asterisks
in B indicate signi¢cant di¡erences between T-cad+ and mock cells
under control aggregation conditions and between T-cad+ cells incu-
bated under control conditions and in the presence of LDL.
*, P6 0.05; **, P6 0.001
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cleavage of precursor protein [39], both precursor and mature
T-cad proteins are constitutively expressed on the cell surface
of SMCs [13,14], tumor-derived endothelial cells and ¢bro-
blasts (unpublished observations). Therefore, it can be pre-
sumed that cell surface expression of precursor T-cad is not
futile. Con¢rmation that precursor T-cad is functional in cell-
cell adhesion, either per se or by facilitating mature T-cad-
mediated cell-cell adhesion, requires model systems in which
endogenous proteolytic conversion to mature protein can be
either maximized (i.e. all mature), completely excluded (i.e. all
precursor) or precisely controlled (controlled proportions of
both). Additional issues concern the mechanism whereby cell-
cell adhesion occurs, the domain(s) of T-cad that are involved
in adhesion and the nature (homo- and/or hetero-epitopic) of
homophilic adhesive interactions.
Our data demonstrating signi¢cantly increased binding of
[125I]-LDL to intact T-cad+ cells (vs. controls) and the nor-
malization of binding after PI-PLC removal of surface T-cad
proteins provide evidence that LDL is a speci¢c ligand for
T-cad. T/E and T/C treatments were not useful for distin-
guishing whether both cell surface precursor and mature
forms of T-cad bind LDL since these treatments increased
non-speci¢c binding of [125I]-LDL to unacceptably high levels.
Unequivocal evaluation of the individual lipoprotein-binding
characteristics of precursor and mature T-cad proteins re-
quires model systems similar to those above-mentioned for
distinguishing individual adhesion characteristics. Neverthe-
less, in consideration of the following two points, we surmise
that both contribute to the increased speci¢c binding observed
in untreated T-cad+ cells. Firstly, ligand-blot analysis shows
that both mature and precursor proteins can bind LDL (this
study and [10,11,14]) and that the two proteins possess indis-
tinguishable LDL-binding characteristics such as a⁄nity,
Ca2 requirement, sensitivity to thiol-group reduction and
ligand selectivity [35,36]. Secondly, since speci¢c ligand-bind-
ing on Western blots has been demonstrated for numerous
well-recognized lipoprotein receptors including apo B,E [40],
LRP [41], gp 330/megalin [42], VLDL receptor [43], HB2 [44]
and SR-B1 [40], LDL-binding to mature and precursor T-cad
protein on blots is unlikely to be artifactual.
We do not yet know which domains of T-cad are involved
in the recognition of LDL. Ligand-binding to T-cad proteins
cannot be detected when electrophoresis is conducted under
reducing conditions [35], suggesting a requirement for intact
disul¢de linkages as is the case for all LDL receptor family
members [34]. The cysteine-rich region of T-cad is located
within the carboxyl-terminal EC5 domain [6], although this
cannot be the sole determinant for LDL recognition by T-cad,
since in spite of identical spacing of cysteine residues in do-
main EC5 [6], N-, P- and E-cadherins do not bind LDL on
ligand-blots (unpublished work). Using peptide-based anti-
sera, we have previously shown that most prominent inhibi-
tion of LDL-binding to puri¢ed mature T-cad on blots was
exerted by antisera targeted to residues 140^161 of T-cad pre-
cursor, these residues corresponding to residues 2^22 in the
NH2-terminal domain, EC1, of mature T-cad [10]. Unfortu-
nately, and probably because of their low a⁄nities, none of
our existing peptide-based antisera and antibodies raised
against puri¢ed mature and precursor human T-cad proteins
was useful as blocking antibody in either aggregation assays
or lipoprotein-binding studies on intact cells (unpublished
work). Nevertheless, studies using epitope-speci¢c blocking
antibodies demonstrated the homotypic interaction site of
the cadherins E, P and N to be located close to the NH2-
terminus of the molecules [18]. If this is also true for T-cad,
then, the ability of LDL to disrupt T-cad-dependent intercel-
lular adhesion might be taken as evidence for some additional
involvement of EC1 in T-cad-LDL interactions. We are cur-
rently engaged in experiments aimed at further characteriza-
tion of LDL-T-cad interactions with respect to both the LDL
recognition domain(s) of T-cad and the T-cad-binding moie-
ty(ies) of LDL.
Inhibition of T-cad-mediated cell-cell adhesion by LDL
provides evidence for a functional consequence of LDL-T-
cad-binding. The physiological relevance of this interaction
remains unclear. HB2 is a membrane protein which has
been attributed adhesive properties in monocytes/macro-
phages [44]. This glycoprotein binds HDL and it was sug-
gested that binding of HDL to HB2 could compete with its
adhesion sites to reduce macrophage migration into the arte-
rial wall [44], a function entirely consistent with the anti-athe-
rogenic role played by HDL. LDL, on the other hand, is a
recognized atherogenic risk factor and in addition to its es-
sential role in cholesterol delivery, there is abundant literature
to indicate that LDL possesses additional, cholesterol-inde-
pendent trophic properties. Since available literature indicates
that T-cad serves a homotypic avoidance mechanism and a
negative function in growth control [9,15^17], we propose that
by binding to T-cad, LDL can interfere with intercellular ad-
hesion and thereby facilitate cell migration and proliferation.
Preliminary studies in our laboratory indicate a reduced pro-
liferation rate in T-cad+ cells (vs. mock and wt cells), which
can be partially ‘normalized’ by LDL (unpublished work).
However, it is likely that LDL-T-cad interactions go beyond
mere physical recognition and that intracellular signalling
processes are involved, and further experiments are planned
to investigate signal transduction responses to homophilic (T-
cad-T-cad) and heterophilic (T-cad-LDL) interactions.
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